US Patent Issued to Celgene on Feb. 17 for "Carboxylic acid containing azetidinyl compounds for the treatment of neurodegenerative diseases" (New Jersey, California, Massachusetts Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,771, issued on Feb. 17, was assigned to Celgene Corp. (Princeton, N.J.).

"Carboxylic acid containing azetidinyl compounds for the treatment of neurodegenerative diseases" was invented by Jeffrey M. Schkeryantz (Summit, N.J.), Karin Worm (Summit, N.J.), Rulin Ma (Winchester, Mass.) and Patrick W. Papa (Carlsbad, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds and compositions thereof for modulating S1P5. In some embodiments, the compounds and compositions are provided for treatment of neurological diseases."

The patent was filed on Jan. 25, 2024, under Application No. 18/422,500.

*For further information, includi...